FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced today that Marc Panoff, the company’s Chief Financial Officer, will present at the Roth Capital Partners 22nd Annual OC Growth Stock Conference. The conference will be held March 15 - 17 at The Ritz Carlton Laguna Niguel in Dana Point, CA.
